These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 11944274)

  • 1. [Application of eloxatin for the treatment of widespread colorectal cancer].
    Miasoiedov DV; Ievtushenko OI; Iugrinov OH
    Klin Khir; 2001 Dec; (12):41-3. PubMed ID: 11944274
    [No Abstract]   [Full Text] [Related]  

  • 2. [Polymorphism in colorectal cancer].
    Hazama S; Oka M; Hinoda Y
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():42-6. PubMed ID: 14574853
    [No Abstract]   [Full Text] [Related]  

  • 3. Optimizing oxaliplatin-based therapy in metastatic colorectal cancer.
    Cassidy J
    Clin Adv Hematol Oncol; 2008 May; 6(5):360-1. PubMed ID: 18516025
    [No Abstract]   [Full Text] [Related]  

  • 4. Oxaliplatin (Eloxatin) for advanced colon cancer.
    Med Lett Drugs Ther; 2003 Jan; 45(1148):7-8. PubMed ID: 12571541
    [No Abstract]   [Full Text] [Related]  

  • 5. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Oxaliplatin -- A 10-Year Trajectory].
    Kanaji S; Oki E; Saeki H; Kitao H; Maehara Y; Kakeji Y
    Gan To Kagaku Ryoho; 2016 Jun; 43(6):715-22. PubMed ID: 27306807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro schedule-dependent interaction between melphalan and oxaliplatin in human colorectal cancer cell lines.
    van Iersel LB; Koudijs TM; Hoekman EJ; Janssen-van Rhijn CM; Vahrmeijer AL; Nortier JW; van de Velde CJ; Gelderblom H; Kuppen PJ
    J Surg Res; 2011 May; 167(2):273-8. PubMed ID: 20036390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 9. Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patients.
    Berretta M; Simonelli C; Lleshi A; Lacchin T; Bearz A; di Gennaro G; Vaccher E; Tirelli U
    Ann Oncol; 2006 Apr; 17(4):721-2. PubMed ID: 16291582
    [No Abstract]   [Full Text] [Related]  

  • 10. The impact of glycemic levels in patients with colon cancer.
    Meyerhardt JA
    Clin Adv Hematol Oncol; 2013 Feb; 11(2):93-4. PubMed ID: 23598910
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities?
    Beretta GD; Scartozzi M; Tondulli L; Cascinu S
    J Clin Oncol; 2010 Jun; 28(16):e268-9; author reply e270. PubMed ID: 20385975
    [No Abstract]   [Full Text] [Related]  

  • 12. A historical perspective on oxaliplatin: rethinking the role of platinum compounds and learning from near misses.
    Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):1-3. PubMed ID: 9609102
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
    Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
    [No Abstract]   [Full Text] [Related]  

  • 15. Oxaliplatin.
    Graham J; Mushin M; Kirkpatrick P
    Nat Rev Drug Discov; 2004 Jan; 3(1):11-2. PubMed ID: 14756144
    [No Abstract]   [Full Text] [Related]  

  • 16. Microsatellite instability in the management of stage II colorectal patients.
    Strâmbu V; Garofil D; Pop F; Radu P; Brătucu M; Iorga C; Iorga R; Pasnicu C; Ion A; Popa F
    Chirurgia (Bucur); 2013; 108(6):816-21. PubMed ID: 24331320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic sinusoidal obstruction syndrome reduces the effect of oxaliplatin in colorectal liver metastases.
    Robinson SM; White SA
    Histopathology; 2012 Dec; 61(6):1247-8. PubMed ID: 23043422
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
    Ducreux M; Louvet C; Bekradda M; Cvitkovic E
    Semin Oncol; 1998 Apr; 25(2 Suppl 5):47-53. PubMed ID: 9609108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxaliplatin].
    Bascioni R
    Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
    [No Abstract]   [Full Text] [Related]  

  • 20. [Oxaliplatin: perspectives and future developments].
    Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
    Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.